Nanjing Xinjiekou to Acquire China Cord Blood for $1.4 Billion

Lock
This article is for subscribers only.

Nanjing Xinjiekou Department Store Co. said it will acquire China Cord Blood Corp. for an estimated 9.01 billion yuan ($1.4 billion).

Xinjiekou will buy a 65.1 percent stake held by Golden Meditech Holdings Ltd. for about 7.26 billion yuan in cash and shares, and buy out minority stakeholders for an estimated 1.75 billion yuan, it said in a statement. The value of Golden Meditech’s stake will be evaluated by a third party at a later date and the two companies will negotiate the price based on the evaluation. In August, Xinjiekou proposed to buy China Cord Blood assets for at least 6 billion yuan in cash, stock, or a combination of both.